Additional quantitative studies on a larger group of HA patients with specific mutations and specific degree of severity as well as on patients with thrombosis will be needed to fully discover the pool of miRNAs that target F8 mRNAs and affect the protein expression leading to bleeding disorders or thrombosis. The gene discussed is F8; the disease is hemorrhagic disease.